Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05150236
Title 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC (EVOLUTION) (EVOLUTION)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
St Vincents Hospital Not yet recruiting Darlinghurst New South Wales 2010 Australia Details
Calvary Mater Newcastle Not yet recruiting Newcastle New South Wales 2298 Australia Details
Royal Brisbane and Womens hospital Not yet recruiting Herston Queensland 4029 Australia Details
Royal Adelaide Hospital Not yet recruiting Adelaide South Australia 5000 Australia Details
Austin Health Not yet recruiting Heidelberg Victoria 3084 Australia Details
Peter MacCallum Cancer Centre Recruiting Melbourne Victoria 3000 Australia Details
Alfred Hospital Not yet recruiting Melbourne Victoria 3004 Australia Details
Sir Charles Gairdner Not yet recruiting Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field